Durability in nucleic acid therapeutics: Delivery barriers, immune constraints, and biological adaptation
Acta Pharmaceutica Sinica B · 2026-11
DOI: 10.1016/j.apsb.2026.11.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Abid Naeem und 2 weiteren Autor:innen. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Fundamental Research Funds for the Central Universities
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
- China Postdoctoral Science Foundation
Zitieren
APA
Naeem, A., Guo, S., & Huang, Y. (2026). Durability in nucleic acid therapeutics: Delivery barriers, immune constraints, and biological adaptation. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2026.11.008
Vancouver
Naeem A, Guo S, Huang Y. Durability in nucleic acid therapeutics: Delivery barriers, immune constraints, and biological adaptation. Acta Pharmaceutica Sinica B. 2026. doi:10.1016/j.apsb.2026.11.008
BibTeX
@article{Naeem2026,
author = {Naeem, Abid and Guo, Shuai and Huang, Yuanyu},
title = {Durability in nucleic acid therapeutics: Delivery barriers, immune constraints, and biological adaptation},
journal = {Acta Pharmaceutica Sinica B},
year = {2026},
doi = {10.1016/j.apsb.2026.11.008}
}
EUVIMED